MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barredo, J.
Right arrow Articles by Moran, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barredo, J.
Right arrow Articles by Moran, R. G.

Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development

J Barredo and RG Moran

Department of Pediatrics and Biochemistry, University of Southern California, Los Angeles 90033.

Previous studies have documented the metabolism of a broad range of folate antimetabolites to polyglutamate derivatives by the enzyme folylpoly-gamma-glutamate synthetase (FPGS). The activity of the more recently developed classes of antifolates directed against thymidylate synthase and de novo purine synthesis is sufficiently dependent on polyglutamation that these compounds should be specifically cytotoxic to any normal or malignant proliferating cell expressing this enzyme. We have studied the patterns of expression of FPGS in mammalian cells and tissues during rapid growth, growth arrest, differentiation, and embryonic development. During embryogenesis in the rat, FPGS levels in liver and brain were higher during the period of proliferative activity and then dropped to a level characteristic of the adult organs. However, the levels in liver were substantially higher than those in brain at any given time. This pattern was mimicked in mouse C3H 10T1/2 embryo fibroblast cells, in which FPGS activity decreased after cessation of growth but then remained at a lower steady state level during an extended period of postconfluent culture. Enzyme activity also dropped after the differentiation of human HL-60 promyelocytic leukemia cells. In a human homolog of these experimental systems, FPGS levels were below the limits of detection in circulating mature human hematopoietic cells of the granulocytic, lymphoblastic, and erythrocytic lineages. In striking contrast, substantial levels of FPGS were found in circulating lymphoblasts from eight patients with acute lymphoblastic leukemia. The levels of FPGS found in these transformed stem cells would help to explain the sensitivity of many acute lymphoblastic leukemias to folate antimetabolites. We concluded that expression of FPGS is regulated by at least two mechanisms, one of which is linked to proliferation and the other of which controls enzyme levels after differentiation and is tissue specific.

Volume 42, Issue 4, pp. 687-694, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. C. Racanelli, F. B. Turner, L.-Y. Xie, S. M. Taylor, and R. G. Moran
A Mouse Gene That Coordinates Epigenetic Controls and Transcriptional Interference To Achieve Tissue-Specific Expression
Mol. Cell. Biol., January 15, 2008; 28(2): 836 - 848.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Odin, Y. Wettergren, S. Nilsson, R. Willen, G. Carlsson, C. P. Spears, L. Larsson, and B. Gustavsson
Altered Gene Expression of Folate Enzymes in Adjacent Mucosa Is Associated with Outcome of Colorectal Cancer Patients
Clin. Cancer Res., December 1, 2003; 9(16): 6012 - 6019.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. J. Leclerc and J. C. Barredo
Folylpoly-{{gamma}}-glutamate Synthetase Gene mRNA Splice Variants and Protein Expression in Primary Human Leukemia Cells, Cell Lines, and Normal Human Tissues
Clin. Cancer Res., April 1, 2001; 7(4): 942 - 951.
[Abstract] [Full Text]


Home page
J. Virol.Home page
G. Gribaudo, L. Riera, D. Lembo, M. De Andrea, M. Gariglio, T. L. Rudge, L. F. Johnson, and S. Landolfo
Murine Cytomegalovirus Stimulates Cellular Thymidylate Synthase Gene Expression in Quiescent Cells and Requires the Enzyme for Replication
J. Virol., June 1, 2000; 74(11): 4979 - 4987.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. J. Peters, E. Smitskamp-Wilms, K. Smid, H. M. Pinedo, and G. Jansen
Determinants of Activity of the Antifolate Thymidylate Synthase Inhibitors Tomudex (ZD1694) and GW1843U89 against Mono- and MultilayeredColon Cancer Cell Lines under Folate-restricted Conditions
Cancer Res., November 1, 1999; 59(21): 5529 - 5535.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Barnes, E. J. Estlin, G. A. Taylor, G. W. Aherne, A. Hardcastle, J. J. McGuire, J. A. Calvete, J. Lunec, A. D. J. Pearson, and D. R. Newell
Impact of Polyglutamation on Sensitivity to Raltitrexed and Methotrexate in Relation to Drug-induced Inhibition of de Novo Thymidylate and Purine Biosynthesis in CCRF-CEM Cell Lines
Clin. Cancer Res., September 1, 1999; 5(9): 2548 - 2558.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Freemantle and R. G. Moran
Transcription of the Human Folylpoly-gamma -glutamate Synthetase Gene
J. Biol. Chem., October 3, 1997; 272(40): 25373 - 25379.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Galpin, J. D. Schuetz, E. Masson, Y. Yanishevski, T. W. Synold, J. C. Barredo, C.-H. Pui, M. V. Relling, and W. E. Evans
Differences in Folylpolyglutamate Synthetase and Dihydrofolate Reductase Expression in Human B-Lineage versus T-Lineage Leukemic Lymphoblasts: Mechanisms for Lineage Differences in Methotrexate Polyglutamylation and Cytotoxicity
Mol. Pharmacol., July 1, 1997; 52(1): 155 - 163.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Roy, K. Mitsugi, and F. M. Sirotnak
Additional Organizational Features of the Murine Folylpolyglutamate Synthetase Gene. TWO REMOTELY SITUATED EXONS ENCODING AN ALTERNATE 5prime END AND PROXIMAL OPEN READING FRAME UNDER THE CONTROL OF A SECOND PROMOTER
J. Biol. Chem., February 28, 1997; 272(9): 5587 - 5593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Roy, K. Mitsugi, and F. M. Sirotnak
Organization and Alternate Splicing of the Murine Folylpolyglutamate Synthetase Gene. DIFFERENT SPLICE VARIANTS IN L1210 CELLS ENCODE MITOCHONDRIAL OR CYTOSOLIC FORMS OF THE ENZYME
J. Biol. Chem., September 27, 1996; 271(39): 23820 - 23827.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, H. Qi, J. Korenberg, T. A. Garrow, Y.-J. Choi, and B. Shane
Purification and Properties of Human Cytosolic Folylpoly-gamma -glutamate Synthetase and Organization, Localization, and Differential Splicing of Its Gene
J. Biol. Chem., May 31, 1996; 271(22): 13077 - 13087.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Roy, K. Mitsugi, S. Sirlin, B. Shane, and F. M. Sirotnak
Different Antifolate-resistant L1210 Cell Variants with either Increased or Decreased Folylpolyglutamate Synthetase Gene Expression at the Level of mRNA Transcription
J. Biol. Chem., November 10, 1995; 270(45): 26918 - 26922.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Freemantle, S. M. Taylor, G. Krystal, and R. G. Moran
Upstream Organization of and Multiple Transcripts from the Human Folylpoly-[IMAGE]-glutamate Synthetase Gene
J. Biol. Chem., April 21, 1995; 270(16): 9579 - 9584.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Egan, S. Sirlin, B. G. Rumberger, T. A. Garrow, B. Shane, and F. M. Sirotnak
Rapid Decline in Folylpolyglutamate Synthetase Activity and Gene Expression during Maturation of HL-60 Cells
J. Biol. Chem., March 10, 1995; 270(10): 5462 - 5468.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics